Health care providers with H-1B-sponsored visas accounted for 0.97% of physicians in the US in fiscal year 2024.
The FDA sent warning letters to fluoride supplement manufacturers telling them not to promote the products for use in young kids.
Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in adults and adolescents with nonsegmental vitiligo.
The greatest rate of treatment persistence in patients with psoriasis following MACE was seen in those receiving biologics vs other treatment types.
Guidelines have been established regarding the definition, diagnosis, and management of persistent chemotherapy-induced alopecia.
The FDA warned consumers about potential serious adverse events linked to radiofrequency microneedling procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback